Metabolic Reprogramming Contributes to Resistance Towards Lenvatinib in Thyroid Cancer
Sonam Kumari, Shilpa Thakur, Stephanie Cardenas, Andrew Makarewicz, and Joanna Klubo-Gwiezdzinska
VideoEndocrinology™: Metabolic Reprogramming Contributes to Resistance Towards Lenvatinib in Thyroid Cancer
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.